Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results. Trump is guilty of mortgage ...

Gain insights into the U.S. market, valued at $5.9 Billion in 2024, and China, forecasted to grow at an impressive 14.4% CAGR to reach $7.8 Billion by 2030. Discover growth trends in other key regions ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...

Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the ‘dark genome’ that are responsible for controlling how cells sense and respond to the ...

Key opportunities in the market include leveraging CRISPR's precision for improved crop traits, meeting food security demands amid climate change, and sustainable agriculture trendsDublin, Dec. 09, ...

Gene-edited goldenberries clear USDA review, moving closer to farms. Compact plants solve farming challenges for this ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Gene therapy could be a permanent cure for many life-threatening hereditary diseases, and this will only help in the treatment of genetic diseases and cancer ...

Using base-editing technology, the pioneering gene therapy (BE-CAR7), has been used to treat a previously untreatable type of ...